Collectively, we identified a list of upregulated surfaceome genes in GBM that include CD44, PTPRJ and HLA-DRA in which their biological relevance in supporting GBM pathogenesis could be comprehensively investigated in future studies for the development of novel GBM diagnostic/prognostic or therapeutic strategies. This evidence concerns the gene PTPRJ and glioblastoma.